Injective (INJ) has recorded a sharp upward move over the past 24 hours, climbing more than 10% to trade above $3.30. By the latest session, INJ peaked around $3.41 before stabilising near $3.35, showing strong intraday demand and elevated trading activity. The token’s sudden strength stood out in an otherwise quiet crypto market, where most major assets were largely flat. The price surge was not random. It came shortly after the launch of US-regulated futures contracts on Bitnomial, a CFTC-regulated exchange. https://twitter.com/injective/status/2044417942423552331?s=20 The launch of US-regulated INJ futures contracts on Bitnomial The introduction of INJ futures on a CFTC-regulated platform marks a meaningful step forward for the asset’s positioning in the broader crypto market. It places Injective alongside a small group of major cryptocurrencies, including Bitcoin (BTC) , Ethereum (ETH), Solana (SOL), and XRP , that already have regulated futures markets in the United States. This matters because regulated futures products open the door to institutional participation in a way that spot markets alone often cannot. Hedge funds, trading firms, and asset managers can now gain exposure to INJ without directly holding the token. That reduces custody friction and expands the range of strategies that can be built around the asset, including hedging and leveraged positioning. More importantly, the launch also begins what many traders refer to as a “track record window.” This is a period where trading activity in regulated futures markets is monitored over time. In practice, this can play a role in strengthening the case for future exchange-traded products, including potential ETF-related structures. INJ price technical analysis Following the ETF news, INJ’s price has broken above its short-term and medium-term moving averages, signalling a shift in momentum after weeks of relatively muted performance. Trading volume has also surged significantly during the move, rising more than 100% above recent averages, suggesting the rally is backed by genuine participation rather than thin liquidity or isolated trading spikes. From a technical perspective, INJ’s strength pushed the Relative Strength Index into the mid-60s range, reflecting a strong momentum without entering overheated territory, which often leaves room for continuation if buying pressure persists. Injective price chart | Source: TradingView At the same time, the price action revealed a clear short-term structure. The $3.20 area has emerged as an important support zone, acting as a key level where buyers have consistently stepped in. On the upside, the $3.41 level has now become an immediate resistance point after being tested during the recent surge. If this level holds, analysts project another attempt to break above $3.41. A successful breakout could open the door toward the next upside area around $3.53, based on commonly tracked technical extensions. On the other hand, a failure to hold the $3.20 support could lead to a retracement back toward the $3.08 region, which would not necessarily invalidate the broader momentum. The post Why is Injective (INJ) surging 10% after US futures launch? appeared first on Invezz
